abs348.txt	in	order	to	explore	the	mechanism	of	the	reversing	multidrug	resistance	(mdr)phenotypes	by	β-elemene	(β-ele)	in	doxorubicin	(dox)-resistant	breast	cancercells	(mcf-7/dox)		both	the	functionality	and	quantity	of	the	abc	transporters	inmcf-7/dox	were	studied		bioluminescence	imaging	(bli)	was	used	to	study	theefflux	of	d-luciferin	potassium	salt		the	substrate	of	atp-binding	cassettetransporters	(abc	transporters)		in	mcf-7/dox	cells	treated	by	β-ele		at	the	sametime	three	major	abc	transport	proteins	and	genes-related	mdr		p-glycoprotein(p-gp		abcb1)	and	multidrug	resistance-associated	protein	1	(mrp		abcc1)	as	wellas	breast	cancer	resistance	protein	(bcrp		abcg2)	were	analyzed	by	q-pcr	andwestern	blot		to	investigate	the	efflux	functionality	of	abc	transporters	mcf-7/doxfluc	cell	line	with	stably-overexpressed	luciferase	was	established		bliwas	then	used	to	real-time	monitor	the	efflux	kinetics	of	d-luciferin	potassiumsalt	before	and	after	mcf-7/doxfluc	cells	being	treated	with	β-ele	or	not		theresults	showed	that	the	efflux	of	d-luciferin	potassium	salt	from	mcf-7/doxflucwas	lessened	when	pretreated	with	β-ele		which	means	that	β-ele	may	dampen	thefunctionality	of	abc	transporters		thus	decrease	the	efflux	of	d-fluoresceinpotassium	or	other	chemotherapies	which	also	serve	as	the	substrates	of	abctransporters		as	the	effect	of	β-ele	on	the	expression	of	abc	transporters		theresults	of	q-pcr	and	western	blot	showed	that	gene	and	protein	expression	of	abctransporters	such	as	p-gp		mrp		and	bcrp	were	down-regulated	after	the	treatmentof	β-ele		to	verify	the	efficacy	of	β-ele	on	reversing	mdr		mcf-7/dox	cells	weretreated	with	the	combination	of	dox	and	β-ele		mtt	assay	showed	that	β-eleincreased	the	inhibitory	effect	of	dox	on	the	proliferation	of	mcf-7/dox		and	theic50	of	the	combination	group	was	much	lower	than	that	of	the	single	dox	or	β-eletreatment		in	all		β-ele	may	reverse	mdr	through	the	substrates	of	abctransporters	by	two	ways		to	lessen	the	abc	protein	efflux	by	weakening	theirfunctionality		or	to	reduce	the	quantity	of	abc	gene	and	protein	expression	
